BIOMEDICAL EXCELLENCE FOR SAFER TRANSFUSION COLLABORATIVE (EIN 050602179) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2004

Legal Domicile

Phone

3108010914

Tax Period

2023-01-01 to 2023-12-31

BIOMEDICAL EXCELLENCE FOR SAFER TRANSFUSION COLLABORATIVE, founded in 2004, is a small nonprofit in the Science & Technology sector that reported $330K in total revenue in fiscal year 2023. Revenue decreased 13% compared to the prior year. Expenses of $395K exceeded revenue, resulting in a 20% operating deficit.

Mission

We are a unique international collaborative of blood providers industry and academic experts that work together to undertake studies publish guidance and recommend procedures aiming to improve the safety quality and effectiveness of transfusion medicine and cellular therapies worldwide. We use our pooled resources to take on projects and challenges that would be unfeasible to address otherwise. We create international impact in transfusion and cellular therapies for the benefit of donors and patients.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $330,000

Program Service Revenue $95

Investment Income $44

Other Revenue $0

TOTAL REVENUE $330,139

Expense Breakdown

Grants Paid $0

Salaries & Benefits $120,000

Fundraising Expenses $0

Program Expenses $353,675

Other Expenses $275,256

TOTAL EXPENSES $395,256

Year-over-Year Comparison

	2023	2022	Change
Revenue	$330,139	$378,796	-0.1%
Expenses	$395,256	$299,996	+0.3%
Net Income	$-65,117	$78,800	-1.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

$120,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Rebecca Cardigan PhD	President	20.00	Officer Director	$0	$0	$0
Zbigniew Szczepiorkowski MD PhD	Treasurer Interim President	20.00	Officer Director	$0	$0	$0
Michael Murphy MD	Consulting Past President	10.00	Officer Director	$0	$0	$0
Dana Devine PhD	Immediate Past President	0.00	Director	$0	$0	$0
David Stroncek MD	Director	5.00	Director	$0	$0	$0
David McKenna MD	Director	5.00	Director	$0	$0	$0
Ralph Vassallo MD	Director	5.00	Director	$0	$0	$0
Marc Germain MD	Director	5.00	Director	$0	$0	$0
Denese Marks PhD	Director	5.00	Director	$0	$0	$0
Jason Acker PhD MBA	Director	5.00	Director	$0	$0	$0
Meghan Delaney DO MPH	Director	5.00	Director	$0	$0	$0
Simon Stanworth MA FCRP PhD FRC	Director	5.00	Director	$0	$0	$0
Eileen Selogie MLS MTASCPSBB	Executive Director	60.00	Director	$120,000	$0	$120,000

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$330,139	$395,256	$837,145	$-65,117
2022	$378,796	$299,996	$902,262	$78,800
2021	$367,660	$162,485	$823,462	$205,175
2020	$223,730	$162,411	$618,287	$61,319

BIOMEDICAL EXCELLENCE FOR SAFER TRANSFUSION COLLABORATIVE